Canada markets open in 2 hours 12 minutes

Bioasis Technologies Inc. (BIOAF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00400.0000 (0.00%)
At close: 10:59AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0040
Open0.0040
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0040 - 0.0040
52 Week Range0.0020 - 0.0180
Volume52,000
Avg. Volume16,696
Market Cap317,656
Beta (5Y Monthly)0.46
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Bioasis Provides Corporate Update and Announces Suspension of Operations

    NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3 ™ platform for delivering therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, today provided an up